After initiating a wind-down more than 18 months ago and exploring liquidation, Galera Therapeutics has found a path forward ...
-- PanGIA Analysis System, a novel machine learning platform for non-invasive diagnosis of oral cancer through an oral sample -- PanGIA Analysis System, a novel machine learning platform for ...
Xtalks is pleased to announce its role as an official Media Partner for the Toronto Life Sciences and Biotech Summit, taking ...
Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...
Clinical Trials Arena on MSN
PDS Biotech’s stock up on colorectal cancer trial success
PDS Biotech has released data from the Phase II investigator-led colorectal cancer trial.
A slow start to 2026 has put first-time biotech financings on course for their worst year since before the pandemic, reducing ...
Seaport Therapeutics, a Boston biotech led by Daphne Zohar, has filed to go public, setting up a Nasdaq debut that could funnel fresh cash into its neuropsychiatric drug pipeline. Spun out of PureTech ...
When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a ...
The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force ...
Biotech held steady in early 2026 as M&A buyouts and rotation from the Magnificent Seven lifted IBB relative strength—read ...
In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy. According to Eli Casdin, CEO of ...
On 16 December 2025, the European Commission proposed a package of measures to improve the health of EU citizens, while ensuring the long-term resilience and competitiveness of the EU health sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results